Navigation Links
Bionomics Achieves US$1 Million Milestone Payment from Genmab
Date:2/19/2008

s for cancer to the clinic."

The CEO of Genmab Lisa N Drakeman, PhD commented: "We are pleased to reach the next level of development with these targets and look forward to continuing the collaboration with Bionomics."

Professor Jan G J van de Winkel, PhD, Chief Scientific Officer of Genmab added: "This milestone has been reached following extensive studies by Genmab on the Bionomics targets. The work we have undertaken has confirmed and extended the work performed by Bionomics, further supporting their potential as new targets for therapeutic antibodies."

Bionomics has the rights and is actively developing a large number of additional proprietary proteins discovered through its angiogenesis program, including BNO69. In addition Bionomics' anti-cancer drug BNC105 will soon commence a Phase 1 clinical trial at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Western Hospital cancer centres in Melbourne for the treatment of solid tumours including breast, colon and prostate cancers. BNC105 was identified using the Angene(R) platform. Bionomics' Investigational New Drug (IND) submission for BNC105 was accepted by the US Food and Drug Administration in November 2007.

About Bionomics Limited:

Bionomics (ASX: BNO) discovers and develops innovative therapeutics for cancer and diseases of the central nervous system. Bionomics has small molecule product development programs in the areas of cancer, anxiety, epilepsy and multiple sclerosis. Bionomics' discovery and development activities are driven by its three technology platforms: Angene(R), the company's angiogenesis target and drug discovery platform, incorporates a variety of genomics tools to identify and validate novel angiogenesis targets. MultiCore(R) is Bionomics' proprietary, diversity orientated chemistry platform for the discovery of small molecule drugs. ionX(R) is a set of novel technologies for the identification of drugs targeting ion channels for diseases of t
'/>"/>

SOURCE Bionomics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
2. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
3. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
4. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
7. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
8. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
9. BioVascular Inc. Closes $10.87 Million Series C Financing
10. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
11. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Md. , Nov. 26, 2014  Over 100 ... of those suffer from this pain daily. Chronic and ... of pain management is born to fulfill the need ... all types of pain. On October 28th, ... the Cumberland, Maryland community.  This ...
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
Breaking Medicine Technology:New Pain Management Center Opens in Cumberland, Md. 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
... PLAINSBORO, N.J., Aug. 1, 2011 Diabetes company ... by Ivy Equities and LCOR in partnership with ... million redevelopment project to completely renovate and upgrade ... Center in Plainsboro, N.J., that will serve as ...
... Mass., Aug. 1, 2011 Hologic, Inc. (Hologic or the ... and supplier of premium diagnostics products, medical imaging systems and ... today announced its results for the third fiscal quarter ended ... quarter include: Revenues of $451.1 million resulting from year-over-year ...
Cached Medicine Technology:Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 2Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 3Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 4Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 5Hologic Announces Third Quarter Fiscal 2011 Operating Results 2Hologic Announces Third Quarter Fiscal 2011 Operating Results 3Hologic Announces Third Quarter Fiscal 2011 Operating Results 4Hologic Announces Third Quarter Fiscal 2011 Operating Results 5Hologic Announces Third Quarter Fiscal 2011 Operating Results 6Hologic Announces Third Quarter Fiscal 2011 Operating Results 7Hologic Announces Third Quarter Fiscal 2011 Operating Results 8Hologic Announces Third Quarter Fiscal 2011 Operating Results 9Hologic Announces Third Quarter Fiscal 2011 Operating Results 10Hologic Announces Third Quarter Fiscal 2011 Operating Results 11Hologic Announces Third Quarter Fiscal 2011 Operating Results 12Hologic Announces Third Quarter Fiscal 2011 Operating Results 13Hologic Announces Third Quarter Fiscal 2011 Operating Results 14Hologic Announces Third Quarter Fiscal 2011 Operating Results 15Hologic Announces Third Quarter Fiscal 2011 Operating Results 16Hologic Announces Third Quarter Fiscal 2011 Operating Results 17Hologic Announces Third Quarter Fiscal 2011 Operating Results 18Hologic Announces Third Quarter Fiscal 2011 Operating Results 19Hologic Announces Third Quarter Fiscal 2011 Operating Results 20
(Date:11/28/2014)... 28, 2014 Brosix is always making ... providing users with a more efficient, effective, and secure ... upgrades, including: , 1. The ability to setup local ... Brosix to better service customers around the globe. , ... servers for large customers that require millions of users ...
(Date:11/28/2014)... Dr. Diane Walder, one of the ... addition of Dr. Bridgit Nolan to her practice as ... having completed her dermatology residency at the University of ... Dr. Nolan to join her practice because ... dermatology. Not only does Dr. Nolan strive to provide ...
(Date:11/28/2014)... New York (PRWEB) November 28, 2014 ... continuing to move forward in New Jersey’s Bergen ... in a consolidated litigation established there is quickly ... List updated on November 18th shows 1,293 lawsuits ... created for lawsuits that allege complications resulting from ...
(Date:11/28/2014)... FL (PRWEB) November 28, 2014 Miami's ... responsive website. Practice founder Dr. Jeffrey Epstein ... Created using a groundbreaking WordPress platform, the site ... , Currently, up to 75% of all ... than ever, these people are logging on with smartphones, ...
(Date:11/28/2014)... Secura Consultants, based in Minneapolis, ... organizations in the country focused on delivering exemplary ... Secura Consultants is proud to offer complimentary Buy-Sell ... a leading global financial company. , Many businesses ... ownership interest comes the need for business succession ...
Breaking Medicine News(10 mins):Health News:Brosix Infrastructure Architecture Changes to Benefit Users 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2
... WASHINGTON, DC, March 7, 2011 The 2011 Sleep in America ... use of communications technology in the hour before bed. It also ... they say they need and are searching for ways to cope. ... week. , The poll found that 43% of Americans between the ...
... For years brain scientists have puzzled over the shadowy role ... present in the brain following an epileptic seizure, but without ... damage that follows a seizure or protect the brain from ... squarely on the side of good: It seems to protect ...
... new gene sites associated with the risk of coronary ... studies. Several of the novel sites discovered in ... Genetics, do not appear to relate to known risk ... "We now have identifed 23 specific genetic ,letters, ...
... symposium, the Society of Surgical Oncology will present the 43rd ... Barrington Hills, IL, for her deep commitment and long-term efforts ... patients get the information they need to make wise decisions ... March 5, at the Society,s 64th annual meeting in San ...
... in your exercise therapy could significantly improve your function ... the March print issue of Stroke: Journal of ... adding family-assisted exercise therapy to routine physical therapy after ... to perform daily living activities. It also lowered the ...
... (HealthDay News) -- Breast cancer survivors may be at increased risk ... chemotherapy and endocrine therapy, a new study suggests. Researchers looked ... of them had experienced a fall in the year before the ... the six-month study period. Those rates are much higher than ...
Cached Medicine News:Health News:Sleepy connected Americans 2Health News:Sleepy connected Americans 3Health News:Sleepy connected Americans 4Health News:Sleepy connected Americans 5Health News:Sleepy connected Americans 6Health News:New role for an old molecule: protecting the brain from epileptic seizures 2Health News:International collaborative identifies 13 new heart-disease-associated gene sites 2Health News:Cancer surgery society presents top honor to Kimberly Duchossois 2Health News:Stroke patients benefit from family involvement in exercise therapy 2Health News:Chemo May Raise Risk of Falls in Breast Cancer Survivors 2
Arthroscopic instrument system for instability and SLAP fixation....
Suture Cutter, Open Ended, Left Notch...
Suture Cutters, Straight...
Portal accessory instrument set. Set also includes a package of 8 mm Guide Wires (.15 cm x 38 cm), and Sterilization Tray....
Medicine Products: